Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Susana Banerjee

1-50 of 129 results

View this query on the Wikidata Query Service
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial

scientific article
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer

article
New strategies in the treatment of ovarian cancer: current clinical perspectives and future potential

scientific article published on 10 January 2013
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

scientific article
Making the best of PARP inhibitors in ovarian cancer

scientific article published on 10 August 2010
Efficacy of chemotherapy in BRCA1/2 mutation carrier ovarian cancer in the setting of PARP inhibitor resistance: a multi-institutional study

scientific article published on 06 August 2013
Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients

scientific article published on 13 July 2016
BRCA somatic mutations and epigenetic BRCA modifications in serous ovarian cancer

scientific article published on March 31, 2016
Mechanisms of disease: angiogenesis and the management of breast cancer

scientific article published on September 2007
Delivering widespread BRCA testing and PARP inhibition to patients with ovarian cancer

scientific article published on 13 December 2016
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers

scientific article
ERBB2 influences the subcellular localization of the estrogen receptor in tamoxifen-resistant MCF-7 cells leading to the activation of AKT and RPS6KA2.

scientific article published on 29 September 2008
Cediranib combined with carboplatin and paclitaxel in patients with metastatic or recurrent cervical cancer (CIRCCa): a randomised, double-blind, placebo-controlled phase 2 trial

scientific article
The future of targeted therapies in ovarian cancer

scientific article published on 10 July 2009
Molecular targets and targeted therapeutics in endometrial cancer

scientific article published on September 2012
The role of targeted therapy in ovarian cancer

scientific article published on September 2011
Trabectedin in advanced uterine leiomyosarcomas: A retrospective case series analysis from two reference centers

scientific article published on 13 September 2011
Management of small HER2-positive breast cancers

scientific article published on December 2010
PARP inhibitors in BRCA gene-mutated ovarian cancer and beyond

scientific article
Enhanced expression of the PDGFR/Abl signaling pathway in aromatase inhibitor-resistant breast cancer

scientific article published on August 2, 2012
Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial

scientific article published on 17 July 2018
New developments in the treatment of ovarian cancer—future perspectives

scientific article published on December 1, 2013
A multicenter, randomized trial of flat dosing versus intrapatient dose escalation of single-agent carboplatin as first-line chemotherapy for advanced ovarian cancer: an SGCTG (SCOTROC 4) and ANZGOG study on behalf of GCIG

scientific article published on October 5, 2012
The integration of BRCA testing into oncology clinics

scientific article published on June 2016
Guidance Statement On BRCA1/2 Tumor Testing in Ovarian Cancer Patients

scientific article published in June 2017
A phase II study of ramucirumab (IMC-1121B) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma.

scientific article published on 10 July 2014
Improving outcomes for older women with gynaecological malignancies

scientific article published on 29 August 2016
Current perspectives on recommendations for BRCA genetic testing in ovarian cancer patients

scientific article published on 4 November 2016
Advanced epithelial ovarian cancer: from standard chemotherapy to promising molecular pathway targets--where are we now?

scientific article published on May 2014
Implications of BRCA1 and BRCA2 mutations for the efficacy of paclitaxel monotherapy in advanced ovarian cancer

scientific article published on 19 December 2012
Global cancer control: responding to the growing burden, rising costs and inequalities in access

scientific article
ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016

scientific article (publication date: 2016)
Olaparib for the treatment of epithelial ovarian cancer

scientific article published on 11 March 2016
Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial

scientific article published on 29 November 2019
The vascular endothelial growth factor receptor inhibitor PTK787/ZK222584 inhibits aromatase

scientific article published on 12 May 2009
Quantitative histology analysis of the ovarian tumour microenvironment.

scientific article
Gender-related challenges facing oncologists: the results of the ESMO Women for Oncology Committee survey

scientific article published on 21 September 2018
FORWARD I: a Phase III study of mirvetuximab soravtansine versus chemotherapy in platinum-resistant ovarian cancer

scientific article published on 9 February 2018
The current status of PARP inhibitors in ovarian cancer

scientific article published on 24 September 2016
Practical guidance on the use of olaparib capsules as maintenance therapy for women with BRCA mutations and platinum-sensitive recurrent ovarian cancer

scientific article
Biological evidence for dual antiangiogenic-antiaromatase activity of the VEGFR inhibitor PTK787/ZK222584 in vivo

scientific article published on 3 August 2010
Burnout in oncologists is a serious issue: What can we do about it?

scientific article published on 16 May 2018
The current status of immunotherapy for cervical cancer

scientific article published on 18 May 2018
Report on the status of women occupying leadership roles in oncology

scientific article published on 21 September 2018
Microenvironmental niche divergence shapes BRCA1-dysregulated ovarian cancer morphological plasticity

scientific article published in Nature Communications
Phase 2 study evaluating intermittent and continuous linsitinib and weekly paclitaxel in patients with recurrent platinum resistant ovarian epithelial cancer

scientific article published on 14 February 2018
The role of Cediranib in ovarian cancer

scientific article published on 21 September 2017
Baseline clinical predictors of antitumor response to the PARP inhibitor olaparib in germline BRCA1/2 mutated patients with advanced ovarian cancer

scientific article published on 10 April 2017
Olaparib and somatic BRCA mutations

scientific article published on 8 June 2017
Venous thromboembolism at time of diagnosis of ovarian cancer: Survival differs in symptomatic and asymptomatic cases

scientific article published on 22 November 2015

Paulina is supported by:

About Paulina

Help